VJGJ, INC., et. al.

  1. June 21, 2022

    Revlon Case Opens, And LATAM Lands Its Ch. 11 Plan

    Cosmetics behemoth Revlon Inc. filed for bankruptcy in the midst of a liquidity crisis, a South American airline brings its Chapter 11 plan in for a landing, and the next phase in Puerto Rico's restructuring nears a creditor vote. This is the week in bankruptcy.

  2. June 17, 2022

    Teligent's Post-Sale Drug Recall Puts Its Ch. 11 Plan In Doubt

    The Chapter 11 plan for the generic-drug maker once known as Teligent Inc. was thrown into doubt Friday after a bankruptcy court ruled that the company owes a refund for drugs it sold after bankruptcy and then later recalled as part of an asset sale.  

  3. May 03, 2022

    Week In Bankruptcy: Purdue On Defense, Becker Goes To Jail

    Purdue Pharma LP told the Second Circuit that decades of precedent justify opioid liability releases given to the Sackler family under its Chapter 11 plan, tennis legend Boris Becker is headed to jail across the pond for hiding assets in bankruptcy, and asbestos claims drove a Hess Corp. subsidiary into bankruptcy in Texas. This is the week in bankruptcy.

  4. April 27, 2022

    Teligent Gets Ch. 11 Disclosure, Voting Plans OK'd In Del.

    Bankrupt pharmaceutical venture Teligent Inc. secured bankruptcy court approval in Delaware Wednesday for its Chapter 11 disclosure statement and confirmation schedule, after a judge stressed a need for greater clarity in identifying liability releases and notifying those giving or getting them.

  5. April 26, 2022

    Week In Bankruptcy: InfoWars' Shaky Start, Releases Still Roil

    Alex Jones moved three holding companies into bankruptcy last week to shield his intellectual property from defamation suits, immediately drawing the ire of the Sandy Hook families that sued him for defamation, the Office of the U.S. Trustee and the judge overseeing the cases; the U.S. trustee continued its national crusade against non-consensual third-party releases; and mass tort cases chugged along. This is the week in bankruptcy.

  6. April 25, 2022

    US Trustee Calls Teligent Ch. 11 Plan Releases 'Baffling'

    The U.S. Trustee's Office on Monday urged a Delaware bankruptcy judge to reject generic pharmaceutical maker Teligent Inc.'s Chapter 11 plan disclosures, saying the statement provides a "baffling" explanation of impermissible, involuntary third-party liability releases.

  7. April 11, 2022

    Teligent OK'd For Fast-Tracked Del. Ch. 11 Disclosure Hearing

    Remnants of bankrupt generic pharmaceutical maker Teligent Inc. secured approval Monday for fast-tracked consideration of a liquidating Chapter 11 plan disclosure statement, after reporting that a $3 million settlement with a second lien creditor will support a better outcome for general unsecured creditors than Chapter 7.

  8. February 24, 2022

    Teligent Says Stalled Plan Talks Make Liquidation Best Option

    Bankrupt generic pharmaceutical company Teligent Inc. told a Delaware bankruptcy judge that an impasse in talks on a restructuring plan and the expiration of its permission to use cash collateral have left it no choice but to pivot to liquidation.

  9. February 08, 2022

    Teligent Lender Slams Creditor Group Bid To Claw Back Cash

    A lender for bankrupt generic pharmaceutical company Teligent Inc. slammed a bid by unsecured creditors for derivative standing to claw back a $10 million reserve fund, insisting the debtor didn't incur any harm by satisfying the lending agreement.

  10. January 18, 2022

    Teligent's 3 Ch. 11 Asset Sales Bring $87M Into Estate

    Bankrupt generic pharmaceutical company Teligent Inc. received court approval Tuesday in Delaware for three asset sales that generated more than $87 million in value for the debtor.